This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Garber, A. M. Articles by Browner, W. S. Search for Related Content PubMed PubMed Citation Articles by Garber, A. M. Articles by Browner, W. S.

(Circulation. 1997;95:1642-1645.)
© 1997 American Heart Association, Inc.

Articles

Cholesterol Screening Guidelines

Consensus, Evidence, and Common Sense

Alan M. Garber, MD, PhD; Warren S. Browner, MD, MPH

From the Veterans Affairs Palo Alto Health Care System and Stanford University (A.M.G.), Stanford, Calif; and San Francisco Department of Veterans Affairs Medical Center and University of California, San Francisco (W.S.B.).

Correspondence to Alan M. Garber, MD, PhD, 204 Junipero Serra Blvd, Stanford, CA 94305. E-mail garber@camis.stanford.edu.

Key Words: cholesterol • tests • hypercholesterolemia

	Introduction

 
In a previous issue of Circulation,¹ the Task Force on Risk Reduction criticized the updated American College of Physicians (ACP) Guidelines for Cholesterol Screening² for "advocating change in the NCEP [National Cholesterol Education Program]/AHA [American Heart Association] guidelines." Implicit in this claim are the beliefs that the NCEP guidelines represent the standard against which all cholesterol screening guidelines should be compared and that the ACP guidelines constitute a reaction to that standard. Neither belief is justified. Furthermore, the task force's comments reflect misunderstandings about the purpose, content, and scientific foundation of the ACP guidelines.

The ACP produced new cholesterol guidelines as part of a periodic review of all of its guidelines. The updated guidelines and background paper³ focused on the questions addressed in the original background paper and guidelines^{4 5} : Which adults should undergo screening for lipoprotein disorders? What tests should be used initially? These questions are more narrowly focused than the range of issues addressed in the NCEP report,⁶ which considered not only the initial screening test but also the sequence of follow-up testing, the criteria for initiation of treatment, and the choice of interventions. Because the effectiveness of screening depends on the steps taken after the result of the screening test is obtained, the ACP implicitly considered some of these issues, but the additional steps were not the subject of recommendations. Thus, the task force mistakenly inferred that the ACP recommended against certain practices proposed by the NCEP (eg, measuring lipoprotein levels in patients with elevated total . . . [Full Text of this Article]

This article has been cited by other articles:

				E. L. Navas-Nacher, L. Colangelo, C. Beam, and P. Greenland Risk Factors for Coronary Heart Disease in Men 18 to 39 Years of Age Ann Intern Med, March 20, 2001; 134(6): 433 - 439. [Abstract] [Full Text] [PDF]

				S. M. Grundy Early Detection of High Cholesterol Levels in Young Adults JAMA, July 19, 2000; 284(3): 365 - 367. [Full Text] [PDF]

				J. A. Milner and R. G. Allison The Role of Dietary Fat in Child Nutrition and Development: Summary of an ASNS Workshop J. Nutr., November 1, 1999; 129(11): 2094 - 2105. [Full Text]

				B. M. Psaty, C. D. Furberg, L. H. Kuller, D. E. Bild, P. M. Rautaharju, J. F. Polak, E. Bovill, and J. S. Gottdiener Traditional Risk Factors and Subclinical Disease Measures as Predictors of First Myocardial Infarction in Older Adults: The Cardiovascular Health Study Arch Intern Med, June 28, 1999; 159(12): 1339 - 1347. [Abstract] [Full Text] [PDF]

				L. P. Lowe, P. Greenland, K. J. Ruth, A. R. Dyer, R. Stamler, and J. Stamler Impact of Major Cardiovascular Disease Risk Factors, Particularly in Combination, on 22-Year Mortality in Women and Men Arch Intern Med, October 12, 1998; 158(18): 2007 - 2014. [Abstract] [Full Text] [PDF]

				R. N. Lemaitre, C. D. Furberg, A. B. Newman, S. B. Hulley, D. J. Gordon, J. S. Gottdiener, R. H. McDonald Jr, and B. M. Psaty Time Trends in the Use of Cholesterol-Lowering Agents in Older Adults: The Cardiovascular Health Study Arch Intern Med, September 14, 1998; 158(16): 1761 - 1768. [Abstract] [Full Text] [PDF]

				S. M. Grundy, G. J. Balady, M. H. Criqui, G. Fletcher, P. Greenland, L. F. Hiratzka, N. Houston-Miller, P. Kris-Etherton, H. M. Krumholz, J. LaRosa, et al. Primary Prevention of Coronary Heart Disease: Guidance From Framingham : A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction Circulation, May 19, 1998; 97(18): 1876 - 1887. [Full Text] [PDF]

				J. I. Cleeman and S. M. Grundy National Cholesterol Education Program Recommendations for Cholesterol Testing in Young Adults : A Science-Based Approach Circulation, March 18, 1997; 95(6): 1646 - 1650. [Full Text]

				J. C. LaRosa and T. A. Pearson Cholesterol Screening Guidelines : Consensus, Evidence, and the Departure From Common Sense Circulation, March 18, 1997; 95(6): 1651 - 1653. [Full Text]